GDC-0152

DB12380InvestigationalSmall molecule

GDC-0152 has been used in trials studying the treatment of Solid Cancers.

Chemical structure of GDC-0152
Formula / weight
C25H34N6O3S · 498.65 g/mol (avg)
Code names
GDC-0152

Resolves to

Compound
UNII4KW1M48SHSCAS873652-48-3ChEMBLCHEMBL2063869PubChem46940575
Structure
InChIKeyWZRFLSDVFPIXOV-LRQRDZAKSA-NSMILESCN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NC1=C(N=NS1)C1=CC=CC=C1
Targets
P98170XIAP

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with GDC-0152, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In